Monday, December 2, 2019

Uses and the side effects of the Gefitinib 250 mg tablet

Uses- Gefitinib is a Chemotherapy medication and its Commercially received approval by FDA in 2003 for the Treatment of patients with Advanced or Metastatic Non-small cell lung cancer whose tumors have specific Mutation in the gene for the Epidermal growth factor Receptor. Gefitinib (Innovator Band- Iressa) blocks a certain type of Protein (An enzyme called Tyrosine Kinase) and interferes with the growth of cancer cells and slows their growth and spread in the body.

Side Effects-  Diarrhea, rash, acne, nausea, vomiting, loss of appetite, nail problems, hair loss, red/sore mouth or throat, Symptoms of Dehydration (Dizziness, dry mouth, fast heartbeat) or unusual weakness may occur if you are on the Treatment of Gefitinib (Geftinat 250 mg by Natco Pharma). If any these side effects Persist please notify your doctor Immediately. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

Storage- Store at room temperature between 20-25 degrees C away from light and moisture.
Iressa/Geftinat (Gefitinib) Availability in India:


Brand Choice- Iressa 250 mg (Manufactured by Astra Zeneca Canada Inc.) and this is available in India also, cost goes around $220 USD for 30 Tablets.

Generic Choice- In India, many generics are available like gefitinib 250 mg by Natco and Geftib by Glenmark etc. Geftinat price in India goes around $80 to $100 USD for 30 Tablets & gefitinib tablet price in china $60 to $80 USD. Patients can purchase online in India.

Read-  Lung cancer and their Treatments​



No comments:

Post a Comment

FDA Greenlights Trastuzumab Deruxtecan for Broad Use in HER2-Positive Cancers

 In a groundbreaking move, the U.S. Food and Drug Administration (FDA) has granted accelerated approval to trastuzumab deruxtecan (Enhertu) ...